{{Redirect-distinguish2|Cedilanide|Cedilanid, a trade name of [[lanatoside C]]}}
{{Drugbox
| verifiedrevid = 460777846
| IUPAC_name = (3β,5β,12β)-3-[(''O''-β-<small>D</small>-glucopyranosyl-(1→4)-''O''-2,6-dideoxy-β-<small>D</small>-''ribo''-hexopyranosyl-(1→4)-''O''-2,6-dideoxy-β-<small>D</small>-''ribo''-hexopyranosyl-(1→4)-2,6-dideoxy-β-<small>D</small>-''ribo''-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
| image = Deslanoside CASCC.png
| width = 324
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|deslanoside}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 6806
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 17598-65-1
| ATC_prefix = C01
| ATC_suffix = AA07
| PubChem = 28620
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01078
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 26618
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = YGY317RK75
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01240
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 31468
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1614
<!--Chemical data-->
| C=47 | H=74 | O=19
| molecular_weight = 943.08 g/mol
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C47H74O19/c1-20-41(64-36-16-30(50)42(21(2)60-36)65-37-17-31(51)43(22(3)61-37)66-44-40(56)39(55)38(54)32(18-48)63-44)29(49)15-35(59-20)62-25-8-10-45(4)24(13-25)6-7-27-28(45)14-33(52)46(5)26(9-11-47(27,46)57)23-12-34(53)58-19-23/h12,20-22,24-33,35-44,48-52,54-57H,6-11,13-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,33-,35+,36+,37+,38-,39+,40-,41-,42-,43-,44+,45+,46+,47+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OBATZBGFDSVCJD-LALPQLPRSA-N
}}
'''Deslanoside''' (trade name '''Cedilanide''' in Brazil<ref>Drugs.com: [http://www.drugs.com/international/cedilanide.html Cedilanide]</ref>) is a [[cardiac glycoside]], a type of drug that can be used in the treatment of [[congestive heart failure]] and [[cardiac arrhythmia]] (irregular heartbeat). It is found in the leaves of ''[[Digitalis lanata]]'', the Woolly Foxglove.<ref>{{Cite journal 
| last1 = Bakke | first1 = O. M. 
| last2 = Aslaksen | first2 = A. 
| last3 = Lehmann | first3 = V. 
| last4 = Lien | first4 = E. 
| title = Pharmacokinetics and serum concentration--effect relationship of intravenous deslanoside 
| journal = Journal of cardiovascular pharmacology 
| volume = 3 
| issue = 5 
| pages = 1015–1025 
| year = 1981 
| pmid = 6168847 | doi=10.1097/00005344-198109000-00012
}}</ref><ref>{{Merck12th|2967}}</ref>

== References ==
{{reflist}}

{{Cardiac glycosides}}

[[Category:Cardenolides]]

{{cardiovascular-drug-stub}}